Humanigen Inc investor relations material
Listen to the latest call from Humanigen Inc
Humanigen, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a portfolio of anti-inflammatory immunology and immuno-oncology monoclonal antibodies in the United States.
Ticker
HGENCountry
USAbout
IR-page